Cite
HARVARD Citation
Tsirogianni, M. et al. (2019). Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine. Leukemia & lymphoma. 60 (10), pp. 2457-2463. [Online].